AcquisitionOther

Salarius Pharmaceuticals, Inc. acquired Hospira, Inc., now a subsidiary of Pfizer. Earlier

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Salarius Pharmaceuticals, Inc. -> Hospira, Inc., now a subsidiary of Pfizer. Earlier · $7 million

This proposed transaction is expected to facilitate multiple value-creating inflection points with Decoy’s pipeline of peptide conjugate therapeutics engineered by its IMP 3 ACT platform, which allows for the rapid computational design and manufacturing of inn

Open source record (SEC) ↗